Login / Signup

Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double-blind randomized sham-controlled study.

François MionSophie MarjouxFabien SubtilMathieu PiocheJerome RivorySabine RomanFrank Zerbib
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2019)
Botulinum toxin injection is not superior to a sham procedure to improve symptoms related to hypercontractile esophageal disorders, suggesting an important placebo effect in for this type of disease. This observation must be taken into account when evaluating more aggressive therapies such as endoscopic myotomy (clinicaltrials.gov: NCT01955174).
Keyphrases